Report Detail
Global Antivenom Market Growth 2019-2024
- RnM2847630 |
- 31 January, 2019 |
- Global |
- 137 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
Asia-Pacific Antivenom market is valued at 285.00 million USD in 2017 and is expected to reach 359.23 million USD by the end of 2023, growing at a CAGR of 43.93% between 2016 and 2022.
The price of Antivenom is slightly increased in nearly five years. For being accorded with the corresponding application area, the product price has a large differences.
Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this areas, the future will still have more new investment enter the field.
According to this study, over the next five years the Antivenom market will register a 2.5% CAGR in terms of revenue, the global market size will reach US$ 960 million by 2024, from US$ 830 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antivenom business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Antivenom market by product type, application, key manufacturers and key regions and countries.
This study considers the Antivenom value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Polyvalent antivenom
Monovalent antivenom
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Retail Pharmacies
Hospitals
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL Behring
Merck & Co.
BTG Plc
Pfizer
Haffkine Bio-Pharmaceutical Corporation
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Antivenom consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Antivenom market by identifying its various subsegments.
Focuses on the key global Antivenom manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antivenom with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Antivenom submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Antivenom Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Antivenom Consumption 2014-2024
- 2.1.2 Antivenom Consumption CAGR by Region
- 2.2 Antivenom Segment by Type
- 2.2.1 Polyvalent antivenom
- 2.2.2 Monovalent antivenom
- 2.3 Antivenom Consumption by Type
- 2.3.1 Global Antivenom Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Antivenom Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Antivenom Sale Price by Type (2014-2019)
- 2.4 Antivenom Segment by Application
- 2.4.1 Retail Pharmacies
- 2.4.2 Hospitals
- 2.4.3 Others
- 2.5 Antivenom Consumption by Application
- 2.5.1 Global Antivenom Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Antivenom Value and Market Share by Application (2014-2019)
- 2.5.3 Global Antivenom Sale Price by Application (2014-2019)
3 Global Antivenom by Players
- 3.1 Global Antivenom Sales Market Share by Players
- 3.1.1 Global Antivenom Sales by Players (2017-2019)
- 3.1.2 Global Antivenom Sales Market Share by Players (2017-2019)
- 3.2 Global Antivenom Revenue Market Share by Players
- 3.2.1 Global Antivenom Revenue by Players (2017-2019)
- 3.2.2 Global Antivenom Revenue Market Share by Players (2017-2019)
- 3.3 Global Antivenom Sale Price by Players
- 3.4 Global Antivenom Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Antivenom Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Antivenom Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Antivenom by Regions
- 4.1 Antivenom by Regions
- 4.1.1 Global Antivenom Consumption by Regions
- 4.1.2 Global Antivenom Value by Regions
- 4.2 Americas Antivenom Consumption Growth
- 4.3 APAC Antivenom Consumption Growth
- 4.4 Europe Antivenom Consumption Growth
- 4.5 Middle East & Africa Antivenom Consumption Growth
5 Americas
- 5.1 Americas Antivenom Consumption by Countries
- 5.1.1 Americas Antivenom Consumption by Countries (2014-2019)
- 5.1.2 Americas Antivenom Value by Countries (2014-2019)
- 5.2 Americas Antivenom Consumption by Type
- 5.3 Americas Antivenom Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Antivenom Consumption by Countries
- 6.1.1 APAC Antivenom Consumption by Countries (2014-2019)
- 6.1.2 APAC Antivenom Value by Countries (2014-2019)
- 6.2 APAC Antivenom Consumption by Type
- 6.3 APAC Antivenom Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Antivenom by Countries
- 7.1.1 Europe Antivenom Consumption by Countries (2014-2019)
- 7.1.2 Europe Antivenom Value by Countries (2014-2019)
- 7.2 Europe Antivenom Consumption by Type
- 7.3 Europe Antivenom Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Antivenom by Countries
- 8.1.1 Middle East & Africa Antivenom Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Antivenom Value by Countries (2014-2019)
- 8.2 Middle East & Africa Antivenom Consumption by Type
- 8.3 Middle East & Africa Antivenom Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Antivenom Distributors
- 10.3 Antivenom Customer
11 Global Antivenom Market Forecast
- 11.1 Global Antivenom Consumption Forecast (2019-2024)
- 11.2 Global Antivenom Forecast by Regions
- 11.2.1 Global Antivenom Forecast by Regions (2019-2024)
- 11.2.2 Global Antivenom Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Antivenom Forecast by Type
- 11.8 Global Antivenom Forecast by Application
12 Key Players Analysis
- 12.1 CSL Behring
- 12.1.1 Company Details
- 12.1.2 Antivenom Product Offered
- 12.1.3 CSL Behring Antivenom Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 CSL Behring News
- 12.2 Merck & Co.
- 12.2.1 Company Details
- 12.2.2 Antivenom Product Offered
- 12.2.3 Merck & Co. Antivenom Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Merck & Co. News
- 12.3 BTG Plc
- 12.3.1 Company Details
- 12.3.2 Antivenom Product Offered
- 12.3.3 BTG Plc Antivenom Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 BTG Plc News
- 12.4 Pfizer
- 12.4.1 Company Details
- 12.4.2 Antivenom Product Offered
- 12.4.3 Pfizer Antivenom Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Pfizer News
- 12.5 Haffkine Bio-Pharmaceutical Corporation
- 12.5.1 Company Details
- 12.5.2 Antivenom Product Offered
- 12.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Haffkine Bio-Pharmaceutical Corporation News
- 12.6 Rare Disease Therapeutics
- 12.6.1 Company Details
- 12.6.2 Antivenom Product Offered
- 12.6.3 Rare Disease Therapeutics Antivenom Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Rare Disease Therapeutics News
- 12.7 Flynn Pharma
- 12.7.1 Company Details
- 12.7.2 Antivenom Product Offered
- 12.7.3 Flynn Pharma Antivenom Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Flynn Pharma News
- 12.8 Vins Bioproducts
- 12.8.1 Company Details
- 12.8.2 Antivenom Product Offered
- 12.8.3 Vins Bioproducts Antivenom Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Vins Bioproducts News
- 12.9 Bharat Serums and Vaccines
- 12.9.1 Company Details
- 12.9.2 Antivenom Product Offered
- 12.9.3 Bharat Serums and Vaccines Antivenom Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Bharat Serums and Vaccines News
- 12.10 Serum Biotech
- 12.10.1 Company Details
- 12.10.2 Antivenom Product Offered
- 12.10.3 Serum Biotech Antivenom Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Serum Biotech News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Antivenom . Industry analysis & Market Report on Antivenom is a syndicated market report, published as Global Antivenom Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Antivenom market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
